Parasol Medtech develops personalized heart devices for safer, more precise stroke prevention in patients with atrial fibrillation.
Parasol Medtech has raised $2.4M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Parasol Medtech is headquartered in Hinsdale, United States.
Parasol Medtech develops personalized heart devices for safer, more precise stroke prevention in patients with atrial fibrillation.
Parasol Medtech is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Parasol Medtech — Funding & Investors." VCBacked, September 10, 2026, https://www.vcbacked.co/company/parasol-medtech. Accessed October 4, 2026.
VCBacked. (2026). Parasol Medtech — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/parasol-medtech
{{cite web |title=Parasol Medtech — Funding & Investors |url=https://www.vcbacked.co/company/parasol-medtech |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated